Dermal safety of soluble denosumab microneedle patches
Treatments studied
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This study tests whether a painless microneedle patch containing the drug denosumab is safe to use on the skin. It is for healthy adults or people with osteoarthritis and osteoporosis who have no skin issues or certain medication use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 70 years old.
- You are healthy or have both osteoarthritis and osteoporosis.
- You have no skin diseases or other serious health conditions.
- You have not taken antihistamines, blood thinners, or steroids in the past month.
- If you could become pregnant, you use birth control before and during the study.
- You are not allergic to ingredients in the patch (PVP or PVA).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether denosumab, a medication that strengthens bones, can also improve muscle strength and insulin sensitivity in postmenopausal women with type 2 diabetes who take metformin.
This trial tests if denosumab, a drug that strengthens bones, can help people with type 2 diabetes who have a high risk of breaking a bone. It is for patients who have had diabetes for a long time or have certain complications.
This study tests a new form of calcium (amorphous calcium carbonate) to see if it can improve bone density in postmenopausal women with osteoporosis. It may offer an alternative for women who cannot or choose not to take other osteoporosis medications.
This trial tests whether a loxoprofen sodium skin patch is absorbed the same way as a reference patch. It is for healthy volunteers to check how the drug behaves in the body.
This study looks at how well and how safely another osteoporosis medicine works for people who have already taken denosumab for 2 years. It may help find the best next step to strengthen bones and lower fracture risk after denosumab.
This trial compares two osteoporosis drugs (romosozumab and denosumab) given alone or together to see which works better for improving bone density. It may help if you are a postmenopausal woman with osteoporosis and have not taken strong bone medications recently.
Hear when a new Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.